Physician profile
George Vinales
NPI 1538454988
$1,002.21
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.02 · 2021: $409 · 2022: $574.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $144.82 | 2021 | |
| Novo Nordisk INC | $123.87 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $113.26 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $80.36 | 2021 | |
| Lilly USA, LLC | $56.11 | 2022 | |
| Pfizer INC. | $54.64 | 2021-2022 | |
| Abbvie INC. | $50.94 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $46.40 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $37.35 | 2022 | |
| Astellas Pharma US INC | $28.80 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $28.03 | 2022 | |
| Edwards Lifesciences Corporation | $24.66 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.06 | 2021 | |
| Biogen, INC. | $21.64 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.21 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $20.78 | 2022 | |
| Alexion Pharmaceuticals, INC. | $19.77 | 2022 | |
| United Therapeutics Corporation | $19.02 | 2019 | |
| Glaxosmithkline, LLC. | $17.00 | 2022 | |
| Merck Sharp & Dohme LLC | $15.46 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.01 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.90 | 2021 | |
| Sanofi-Aventis U.S. LLC | $13.58 | 2022 | |
| Nestle Healthcare Nutrition INC. | $13.54 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Vinales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.